NexImmune's Seed VC Round

NexImmune raised a round of funding on July 22, 2014.

NexImmune is an early stage biopharmaceutical company developing immuno-therapeutics based on the Artificial IMmune (AIM) technology. The AIM technology provides an important advance in the developmen…

Articles about NexImmune's Seed VC Round: